With new advisory committee, FDA signals increased focus on digital health, Vold says

Partner Aleksandra Vold is quoted in the Oct. 18 issue of The Capitol Forum, titled "Health Care Antitrust Weekly: Khan Seeks Doctors' Input on Impact of Private Equity in Health Care; FDA Tackles Health Data Security Amid Broader Enforcement Push from FTC."

Vold's remarks relate to the Food and Drug Administration's new Digital Health Advisory Committee and what the committee's formation means. "The FDA's focus on digital health through this new advisory committee signals to me that it has identified what many practitioners have been confronting for the last several years: the line separating clinical decision support software (regulated) and a 'resource' (unregulated) is grayer than it ever has been with the rapid adoption and evolution of AI tools," she says.

Read the issue (subscription required).